EGFR-Mutant Adenocarcinomas That Transform to Small-Cell Lung Cancer and Other Neuroendocrine Carcinomas: Clinical Outcomes

PURPOSE: Approximately 3% to 10% of EGFR (epidermal growth factor receptor) -mutant non–small cell lung cancers (NSCLCs) undergo transformation to small-cell lung cancer (SCLC), but their clinical course is poorly characterized. METHODS: We retrospectively identified patients with EGFR-mutant SCLC a...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Τόπος έκδοσης:J Clin Oncol
Κύριοι συγγραφείς: Marcoux, Nicolas, Gettinger, Scott N., O’Kane, Grainne, Arbour, Kathryn C., Neal, Joel W., Husain, Hatim, Evans, Tracey L., Brahmer, Julie R., Muzikansky, Alona, Bonomi, Philip D., del Prete, Salvatore, Wurtz, Anna, Farago, Anna F., Dias-Santagata, Dora, Mino-Kenudson, Mari, Reckamp, Karen L., Yu, Helena A., Wakelee, Heather A., Shepherd, Frances A., Piotrowska, Zofia, Sequist, Lecia V.
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: American Society of Clinical Oncology 2019
Θέματα:
RAPID COMMUNICATIONS
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7001776/
https://ncbi.nlm.nih.gov/pubmed/30550363
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.18.01585
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια